Emergent Invests $50M to Expand Fill/Finish Facility

Multi-year investment will support growth of contract development and manufacturing capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Emergent BioSolutions has unveiled plans for the beginning of a $50 million expansion to the company’s Camden fill/finish facility located in Baltimore, MD. The multi-year expansion is expected to be completed in 2021, and will significantly increase the company’s contract development and manufacturing capacity, redundancy, and flexibility. This expansion is also anticipated to create up to 60 new jobs in the next three years. “The expansion of our Camden facility is a signi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters